{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:33:33Z","timestamp":1794047613125,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.drugalcdep.2007.05.028","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:22:42Z","timestamp":1184656962000},"page":"141-148","source":"Crossref","is-referenced-by-count":46,"title":["A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence"],"prefix":"10.1016","volume":"91","author":[{"given":"Theresa","family":"Winhusen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Somoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenic A.","family":"Ciraulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy M.","family":"Harrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence S.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Mindrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabuhi","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juris","family":"Mezinskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elkashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2007.05.028_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00003495-199855030-00013","article-title":"Tiagabine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy","volume":"55","author":"Adkins","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archpsyc.1994.03950120061010","article-title":"One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects","volume":"51","author":"Carroll","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.drugalcdep.2007.05.028_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jat\/19.6.459","article-title":"Pharmacokinetics and pharmacodynamics of cocaine","volume":"19","author":"Cone","year":"1995","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0376-8716(01)00163-6","article-title":"GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings","volume":"65","author":"Cousins","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050937","article-title":"Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats","volume":"143","author":"Campbell","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","article-title":"The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties","volume":"68","author":"Fals-Stewart","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonz\u00e1lez","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine (benzoylecgonine) free urines in recently admitted cocaine-dependent methadone treated patients: preliminary results of a randomized clinical trial","volume":"98","author":"Gonz\u00e1lez","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1176\/ajp.148.5.630","article-title":"Outcomes for cocaine abusers after once-a-week psychosocial therapy","volume":"148","author":"Kang","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1176\/jnp.9.3.482","article-title":"The neurobiology of drug addiction","volume":"9","author":"Koob","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib12","first-page":"1942","article-title":"Comparison of the effects of vagabatrin on cocaine self-administration and food reinforcement","author":"Kushner","year":"1997","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002130050418","article-title":"The effects of gamma-vinyl GABA on cocaine-induced lowering of brain-stimulation reward thresholds","volume":"133","author":"Kushner","year":"1997","journal-title":"Pychopharmacology"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0306-3623(96)00357-6","article-title":"Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex","volume":"28","author":"Leach","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3928\/0048-5713-19981001-08","article-title":"Craving and withdrawal symptoms for various drugs of abuse","volume":"28","author":"Mezinskis","year":"1998","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1098-2396(199801)28:1<60::AID-SYN7>3.0.CO;2-A","article-title":"Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine","volume":"28","author":"Morgan","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1360-0443.1997.tb02938.x","article-title":"Assessment of cocaine use with quantitative urinalysis and estimation of new uses","volume":"92","author":"Preston","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib19","unstructured":"SAS Institute Inc. SAS\/STAT software, Version 9.1 of the SAS System for Microsoft Windows. Copyright \u00a9 (2002\u20132003), Cary, NC, USA: SAS Institute Inc."},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib20","series-title":"Techniques to Assess Alcohol Consumption","first-page":"19","article-title":"Timeline follow back: a technique for assessing self-reported ethanol consumption","author":"Sobell","year":"1992"},{"issue":"Suppl. 6","key":"10.1016\/j.drugalcdep.2007.05.028_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb06011.x","article-title":"Tiagabine monotherapy in the treatment of partial epilepsy","volume":"36","author":"Schachter","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib22","series-title":"Elements of Statistical Computing","author":"Thisted","year":"1988"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib23","first-page":"180","article-title":"The Substance Clinical Global Impression (SCGI) Scale: measuring global functioning in substance related clinical trials","author":"Tracy","year":"2000","journal-title":"NIDA Res Mon"},{"key":"10.1016\/j.drugalcdep.2007.05.028_bib24","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","article-title":"Medication development for addictive disorders: the state of the science","volume":"162","author":"Vocci","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2007.05.028_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","article-title":"A placebo-controlled screening trial of tiagabine, sertraline, and donepezil as cocaine dependence treatments","volume":"100","author":"Winhusen","year":"2005","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607002384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607002384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T21:24:18Z","timestamp":1546723458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871607002384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":25,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0376871607002384"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.028","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}